Late-Term Clinical Outcomes With Zotarolimus- and...

Late-Term Clinical Outcomes With Zotarolimus- and Sirolimus-Eluting Stents: 5-Year Follow-Up of the ENDEAVOR III (A Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions)

David E. Kandzari, Laura Mauri, Jeffrey J. Popma, Mark A. Turco, Paul A. Gurbel, Peter J. Fitzgerald, Martin B. Leon
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
4
Year:
2011
Language:
english
Pages:
8
DOI:
10.1016/j.jcin.2010.12.014
File:
PDF, 704 KB
english, 2011
Conversion to is in progress
Conversion to is failed